Personas / Equipo Humano

Angel Montero Carcaboso

Buscador de publicaciones

Publicaciones

  • Janin M, Ortiz-Barahona V, de Moura MC, Martínez-Cardús A, Llinàs-Arias P, Soler-Vila M, Nachmani D, Pelletier J, Schumann U, Calleja-Cervantes ME, Moran S, Guil S, Bueno-Costa A, Piñeyro D, Perez-Salvia M, Rosselló-Tortella M, Piqué L, Bech-Serra JJ, De La Torre C, Vidal A, Martínez-Iniesta M, Martín-Tejera JF, Villanueva A, Arias A, Cuartas I, Aransay AM, Morales-La Madrid A, Carcaboso AM, Santa-María López V, Mora J, Fernandez AF, Fraga MF, Aldecoa I, Pedrosa L, Graus F, Vidal N, Martínez-Soler F, Tortosa A, Carrato C, Balañá C, Boudreau MW, Hergenrother PJ, Kötter P, Entian KD, Hench J, Frank S, Mansouri S, Zadeh G, Dans PD, Orozco M, Thomas G, Blanco S, Seoane J, Preiss T, Pandolfi PP and Esteller M.

    Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program

    ACTA NEUROPATHOLOGICA . 138(6): 1053-1074. Nº de citas: 123

    [doi:10.1007/s00401-019-02062-4]

  • Munier FL, Beck-Popovic M, Chantada G, Cobrinik D, Kivelä TT, Lohmann D, Maeder P, Moll AC, Carcaboso AM, Moulin A, Schaiquevich P, Bergin C, Dyson PJ, Houghton S, Puccinelli F, Vial Y, Gaillard MC and Stathopoulos C.

    Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. "Alive, with good vision and no comorbidity"

    PROGRESS IN RETINAL AND EYE RESEARCH . 73: 100764-100764. Nº de citas: 131

    [doi:10.1016/j.preteyeres.2019.05.005]

  • Zaritski A, Castillo H, Kumarasamy M, Peled E, Sverdlov Arzi R, Carcaboso AM and Sosnik A.

    Selective Accumulation of Galactomannan Amphiphilic Nanomaterials in Pediatric Solid Tumor Xenografts Correlates with GLUT1 Gene Expression

    ACS APPLIED MATERIALS & INTERFACES . 11(42): 38483-38496. Nº de citas: 22

    [doi:10.1021/acsami.9b12682]

  • Katagi H, Louis N, Unruh D, Sasaki T, He X, Zhang A, Ma Q, Piunti A, Shimazu Y, Lamano JB, Carcaboso AM, Tian X, Seluanov A, Gorbunova V, Laurie KL, Kondo A, Wadhwani NR, Lulla R, Goldman S, Venneti S, Becher OJ, Zou L, Shilatifard A and Hashizume R.

    Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma

    CLINICAL CANCER RESEARCH . 25(18): 5572-5583. Nº de citas: 57

    [doi:10.1158/1078-0432.CCR-18-3890]

  • Fons NR, Sundaram RK, Breuer GA, Peng S, McLean RL, Kalathil AN, Schmidt MS, Carvalho DM, Mackay A, Jones C, Carcaboso AM, Nazarian J, Berens ME, Brenner C and Bindra RS.

    PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma

    NATURE COMMUNICATIONS . 10: 3790-3790. Nº de citas: 55

    [doi:10.1038/s41467-019-11732-6]

  • Koncar RF, Dey BR, Stanton AJ, Agrawal N, Wassell ML, McCarl LH, Locke AL, Sanders L, Morozova-Vaske O, Myers MI, Hamilton RL, Carcaboso AM, Kohanbash G, Hu B, Amankulor NM, Felker J, Kambhampati M, Nazarian J, Becher OJ, James CD, Hashizume R, Broniscer A, Pollack IF and Agnihotri S.

    Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas

    CANCER RESEARCH . 79(16): 4026-4041. Nº de citas: 22

    [doi:10.1158/0008-5472.CAN-18-3521]

  • Carvalho D, Taylor KR, Gene-Olaciregui N, Molinari V, Clarke M, Mackay A, Ruddle R, Henley A, Valenti M, Hayes A, Brandon AH, Eccles SA, Raynaud F, Boudhar A, Monje M, Popov S, Moore AS, Mora J, Cruz-Martínez O, Vinci M, Brennan PE, Bullock AN, Carcaboso AM and Jones C.

    ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma

    Communications Biology . 2: 156-156. Nº de citas: 67

    [doi:10.1038/s42003-019-0420-8]

  • Przystal JM, Waramit S, Pranjol MZI, Yan W, Chu G, Chongchai A, Samarth G, Gene-Olaciregui N, Tabatabai G, Carcaboso AM, Aboagye EO, Suwan K and Hajitou A.

    Efficacy of systemic temozolomide-activated phage-targeted gene therapy in human glioblastoma

    EMBO Molecular Medicine . 11(4): . Nº de citas: 58

    [doi:10.15252/emmm.201708492]

  • Puerto-Camacho P, Amaral AT, Lamhamedi-Cherradi SE, Menegaz BA, Castillo H, Ordóñez JL, Dominguez-Hormaetxe S, Jordan-Perez C, Diaz-Martin J, Romero-Pérez L, Lopez-Alvarez M, Civantos-Jubera G, Robles-Frias MJ, Biscuola M, Ferrer C, Mora J, Cuglievan B, Schadler KL, Seifert O, Kontermann RE, Pfizenmaier K, Simon L, Fabre M, Carcaboso AM, Ludwig JA and de Álava E.

    Preclinical Efficacy of Endoglin-Targeting Antibody-Drug Conjugates for the Treatment of Ewing Sarcoma

    CLINICAL CANCER RESEARCH . 25(7): 2228-2240. Nº de citas: 30

    [doi:10.1158/1078-0432.CCR-18-0936]

  • Asnaghi L, White DT, Key N, Choi J, Mahale A, Alkatan H, Edward DP, Elkhamary SM, Al-Mesfer S, Maktabi A, Hurtado CG, Lee GY, Carcaboso AM, Mumm JS, Safieh LA and Eberhart CG.

    ACVR1C/SMAD2 signaling promotes invasion and growth in retinoblastoma

    Oncogene . 38(12): 2056-2075. Nº de citas: 34

    [doi:10.1038/s41388-018-0543-2]